Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
ESMO Open
|
July 7, 2023
Learning lessons from the COVID-19 pandemic for real-world evidence research in oncology-shared perspectives from international consortia
L Castelo-Branco, R Lee, M Brandão, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 11, 2022
A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions
A Cortellini, A P C Barrichello, J V Alessi, et al.
Alimentary Pharmacology & Therapeutics
|
March 3, 2017
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study
J Howell, D J Pinato, R Ramaswami, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 3, 2026
Cytokine Release Symptoms rather than Syndromes: A call for Granular Reporting of Cytokine Related Adverse Events in Clinical Trials
J-D Fumet, M Roulleaux Dugage, F-X Danlos, et al.
Alimentary Pharmacology & Therapeutics
|
October 17, 2017
The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinoma
D J Pinato, R Sharma, C Citti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 17, 2021
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy
A Cortellini, B Ricciuti, F Facchinetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2022
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS<sup>G12D</sup>-mutated non-small-cell lung cancer
B Ricciuti, J V Alessi, A Elkrief, et al.
ESMO Open
|
October 8, 2022
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis
M Rimini, L Rimassa, K Ueshima, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
ESMO Open
|
July 7, 2023
Learning lessons from the COVID-19 pandemic for real-world evidence research in oncology-shared perspectives from international consortia
L Castelo-Branco, R Lee, M Brandão, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 11, 2022
A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions
A Cortellini, A P C Barrichello, J V Alessi, et al.
Alimentary Pharmacology & Therapeutics
|
March 3, 2017
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study
J Howell, D J Pinato, R Ramaswami, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 3, 2026
Cytokine Release Symptoms rather than Syndromes: A call for Granular Reporting of Cytokine Related Adverse Events in Clinical Trials
J-D Fumet, M Roulleaux Dugage, F-X Danlos, et al.
Alimentary Pharmacology & Therapeutics
|
October 17, 2017
The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinoma
D J Pinato, R Sharma, C Citti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 17, 2021
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy
A Cortellini, B Ricciuti, F Facchinetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2022
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS<sup>G12D</sup>-mutated non-small-cell lung cancer
B Ricciuti, J V Alessi, A Elkrief, et al.
ESMO Open
|
October 8, 2022
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis
M Rimini, L Rimassa, K Ueshima, et al.
Page
of 3